168 related articles for article (PubMed ID: 2997989)
1. Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells.
Williams MV; Holliday J; Glaser R
Virology; 1985 Apr; 142(2):326-33. PubMed ID: 2997989
[TBL] [Abstract][Full Text] [Related]
2. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells.
Ooka T; Lenoir GM; Decaussin G; Bornkamm GW; Daillie J
J Virol; 1986 May; 58(2):671-5. PubMed ID: 3009879
[TBL] [Abstract][Full Text] [Related]
4. Expression of viral and human dUTPase in Epstein-Barr virus-associated diseases.
Fleischmann J; Kremmer E; Greenspan JS; Grässer FA; Niedobitek G
J Med Virol; 2002 Dec; 68(4):568-73. PubMed ID: 12376965
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-encoded deoxyuridine triphosphate nucleotidohydrolase (dUTPase): a potential target for drug therapy.
Kremmer E; Sommer P; Grässer FA
Transplant Proc; 1997; 29(1-2):812-4. PubMed ID: 9123537
[No Abstract] [Full Text] [Related]
6. Induction of Epstein-Barr virus-associated DNA polymerase by 12-O-tetradecanoylphorbol-13-acetate. Purification and characterization.
Datta AK; Feighny RJ; Pagano JS
J Biol Chem; 1980 Jun; 255(11):5120-5. PubMed ID: 6246099
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
Datta AK; Hood RE
Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
[No Abstract] [Full Text] [Related]
8. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes.
Lin JC; Smith MC
Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048
[TBL] [Abstract][Full Text] [Related]
10. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
[TBL] [Abstract][Full Text] [Related]
11. Cloning and expression of the Epstein-Barr virus-encoded dUTPase: patients with acute, reactivated or chronic virus infection develop antibodies against the enzyme.
Sommer P; Kremmer E; Bier S; König S; Zalud P; Zeppezauer M; Jones JF; Mueller-Lantzsch N; Grässer FA
J Gen Virol; 1996 Nov; 77 ( Pt 11)():2795-805. PubMed ID: 8922474
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded dUTPase modulates immune function and induces sickness behavior in mice.
Padgett DA; Hotchkiss AK; Pyter LM; Nelson RJ; Yang E; Yeh PE; Litsky M; Williams M; Glaser R
J Med Virol; 2004 Nov; 74(3):442-8. PubMed ID: 15368518
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-specific DNase activity in nonproducer Raji cells after treatment with 12-o-tetradecanoylphorbol-13-acetate and sodium butyrate.
Ooka T; De Turenne M; De The G; Daillie J
J Virol; 1984 Feb; 49(2):626-8. PubMed ID: 6319766
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of a stimulatory protein for virus-specified DNA polymerase in phorbol ester-treated Epstein-Barr virus-carrying cells.
Chiou JF; Li JK; Cheng YC
Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5728-31. PubMed ID: 2994045
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a DNase induced by Epstein-Barr virus.
Tan RS; Datta AK; Cheng YC
J Virol; 1982 Dec; 44(3):893-9. PubMed ID: 6294337
[TBL] [Abstract][Full Text] [Related]
16. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
Margalith M; Manor D; Usieli V; Goldblum N
Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504
[No Abstract] [Full Text] [Related]
17. Steroids inhibit tumor promoting agent induced Epstein-Barr virus early antigens in Raji cells.
Sundar SK; Ablashi DV; Armstrong GR; Zipkin M; Faggioni A; Levine PH
Int J Cancer; 1981 Oct; 28(4):503-7. PubMed ID: 6273335
[TBL] [Abstract][Full Text] [Related]
18. Calcium modulation activates Epstein-Barr virus genome in latently infected cells.
Faggioni A; Zompetta C; Grimaldi S; Barile G; Frati L; Lazdins J
Science; 1986 Jun; 232(4757):1554-6. PubMed ID: 3012779
[TBL] [Abstract][Full Text] [Related]
19. Differential cytotoxicity of tumour promoter TPA for EBV-negative human lymphoma cell lines and their EBV-converted sublines.
Béchet JM; Guétard D
Int J Cancer; 1983 Jul; 32(1):61-5. PubMed ID: 6305854
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk.
Waldman WJ; Williams MV; Lemeshow S; Binkley P; Guttridge D; Kiecolt-Glaser JK; Knight DA; Ladner KJ; Glaser R
Brain Behav Immun; 2008 Feb; 22(2):215-23. PubMed ID: 17845840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
